Kodiak Sciences Inc

Call
Website
1250 Page Mill Rd
Palo Alto, CA 94304
+1 (650) 281-0850
https://kodiak.com

Kodiak Sciences Inc. is a biopharmaceutical company based in Palo Alto, California, dedicated to researching, developing, and commercializing innovative therapies for high-prevalence retinal diseases. The company focuses on addressing significant conditions such as age-related macular degeneration and diabetic retinopathy, aiming to improve the quality of life for millions affected by these conditions.

Utilizing its proprietary ABC platform, Kodiak is advancing a pipeline of novel treatments, including bispecific antibody biopolymer conjugates. The company's commitment to scientific excellence is reflected in its ongoing clinical trials and recent positive results, reinforcing its mission to transform the landscape of ocular disease treatment.

Generated from the website

Own this business?
See a problem?

You might also like

Song writings, Blood derivatives

Anvil Biosciences

Anvil Biosciences is a biotechnology company located in Hayward, California, which saw its assets acquired between 2017 and 2018. The acquisition marked a significant transition for the company, positioning it for future developments in the biotech field. Following the acquisition, Anvil Biosciences has shifted its focus, with notable activities continuing into 2019. This evolution highlights the company's commitment to advancing its capabilities in biotechnology. Generated from the website
ThermoFisher SSF Cafeteria
Scientific instruments, Services, nec, nec, Business services, nec, nec

ThermoFisher SSF Cafeteria

4
"Love it ! Definitely recommended! Hahaha Also love the sushi , pho noodles and empanadas Definitely come and try it out"
photo of Chengjing L.
Eureka Therapeutics Inc
Biotechnical research, noncommercial, Blood derivatives, Biological research

Eureka Therapeutics Inc

Eureka Therapeutics Inc, located in Emeryville, CA, is a biotechnology company specializing in innovative therapies for cancer treatment. Their cutting-edge technologies, including the E-ALPHA Phage Display Platform and ARTEMIS Cell Receptor Platform, have gained recognition in the scientific community and have been published in numerous scientific publications. With a strong focus on T-cell therapy, Eureka Therapeutics aims to revolutionize cancer treatment by developing personalized therapies that harness the power of the patient's own immune system. Led by their experienced Chief Financial Officer, Alexa Willson, the company benefits from her extensive background in corporate finance and strategy, as well as her expertise in capital raising and mergers and acquisitions.Generated from the website
United States›California›Palo Alto›Kodiak Sciences Inc

Partial Data by Infogroup (c) 2025. All rights reserved.